The FDA announced today that a Philips recall involving remote cardiac monitoring software is Class I, its most serious ...

Inquis Medical announced today that it completed enrollment in a pivotal trial evaluating its Aventus thrombectomy system.

Medtronic (NYSE: MDT) announced today that it received CE mark approval for its BrainSense adaptive deep brian stimulation ...

SS Innovations announced today that surgeons completed the world's first robotic cardiac telesurgeries using its Mantra ...

Medtronic (NYSE: MDT) announced today that it entered into an exclusive U.S. distribution agreement with Contego Medical.

Q'Apel Medical today announced it received CE mark certification for its Armadillo SelectFlex Neurovascular Access System.

Synchron announced today that it partnered with Nvidia to advance its brain-computer interface (BCI) technology.

Johnson & Johnson MedTech (NYSE: JNJ) announced that it received CE mark approval for its dual-energy ThermoCool SmartTouch ...

Pulse Biosciences announced today that it appointed Paul A. LaViolette, co-chair of its board, as its new CEO.

Relief Cardiovascular has closed a $12 million Series A round to help initiate a first-in-human feasibility study for its ...

Johnson & Johnson MedTech has temporarily paused all U.S. external evaluations and cases using its Varipulse pulse field ...

It’s incredibly rewarding to build in the medtech space, but some data suggests the average medical device requires $31 ...